Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10595557 | 0.73 | — | — | |
| SCHEMBL3192528 | 0.71 | — | — | |
| SCHEMBL11414414 | 0.69 | — | — | |
| SCHEMBL29889544 | 0.68 | LMNA (0.31) | LMNA | |
| SCHEMBL20094563 | 0.68 | LMNA (0.39) | LMNAKDM4EALDH1A1GAATSHR | |
| SCHEMBL22007000 | 0.68 | LMNA (0.39) | LMNAKDM4EALDH1A1GAATSHR | |
| SCHEMBL2758566 | 0.67 | GLA (0.33) | LMNAKDM4EALDH1A1GAATSHR | |
| SCHEMBL31376461 | 0.65 | LMNA (0.35) | LMNAKDM4EALDH1A1GAA | |
| SCHEMBL31648648 | 0.65 | — | — | |
| SCHEMBL30180803 | 0.64 | LMNA (0.31) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0076075-A1 | Pharmaceutically active benzopyran compounds | BEECHAM GROUP PLC (GB) | 1983-04-06 | — | — | EP | claimed |
| US-20250257056-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-08-14 | — | — | US | disclosed |
| US-12319672-B2 | Alpha-D-galactopyranoside derivatives | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-06-03 | — | — | US | disclosed |
| WO-2025024707-A1 | INHIBITORS OF CDK2/4/6 KINASE | KINNATE BIOPHARMA INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| EP-4097138-A1 | ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS | Avila Therapeutics, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| US-20220281855-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2022-09-08 | — | — | US | disclosed |
| CN-103080106-A | Cyclic ether compounds useful as kinase inhibitors | NOVARTIS AG | 2013-05-01 | — | — | CN | disclosed |
| CN-100390153-C | Intermediate for producing novel pyrazine derivatives | TOYAMA CHEMICAL CO LTD (JP) | 2008-05-28 | — | — | CN | disclosed |
| CN-1781911-A | Intermediate for producing novel pyrazine derivatives | TOYAMA CHEMICAL CO LTD (JP) | 2006-06-07 | — | — | CN | disclosed |
| CN-1239511-C | Novel pyrazine derivative or salt thereof, and pharmaceutical composition containing the same | TOYAMA CHEMICAL CO LTD (JP) | 2006-02-01 | — | — | CN | disclosed |
| CN-1418220-A | Novel pyrazine derivative or salt thereof, pharmaceutical composition containing same, and intermediate for producing both | TOYAMA CHEMICAL CO LTD (JP) | 2003-05-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257056-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | LGALS1, LGALS3, LGALS2 | LMNA 964/4885KDM4E 4329/4885ALDH1A1 251/4885 |
| US-20220281855-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | LGALS1, LGALS3, LGALS2 | LMNA 1998/4885KDM4E 4515/4885ALDH1A1 134/4885 |
| US-12319672-B2 | Alpha-D-galactopyranoside derivatives | LGALS1, LGALS3, LGALS2 | LMNA 1998/4885KDM4E 4515/4885ALDH1A1 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.